BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27798027)

  • 1. Possible role of IL-6 and TIE2 gene polymorphisms in predicting the initial high transport status in patients with peritoneal dialysis: an observational study.
    Ding L; Shao X; Cao L; Fang W; Yan H; Huang J; Gu A; Yu Z; Qi C; Chang X; Ni Z
    BMJ Open; 2016 Oct; 6(10):e012967. PubMed ID: 27798027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between interleukin-10 gene polymorphism -592 (A/C) and peritoneal transport in patients undergoing peritoneal dialysis.
    Lee YT; Tsai YC; Yang YK; Hsu KT; Liao SC; Wu CH; Cheng BC; Chen JB; Lee CH; Lee CT
    Nephrology (Carlton); 2011 Sep; 16(7):663-71. PubMed ID: 21777343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of ENOS and RAS gene polymorphisms to initial peritoneal transport status in peritoneal dialysis patients.
    Akcay A; Micozkadioglu H; Atac FB; Agca E; Ozdemir FN
    Nephron Clin Pract; 2006; 104(1):c41-6. PubMed ID: 16741369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline higher peritoneal transport had been associated with worse nutritional status of incident continuous ambulatory peritoneal dialysis patients in Southern China: a 1-year prospective study.
    Liu Y; Huang R; Guo Q; Yang Q; Yi C; Lin J; Yu X; Yang X
    Br J Nutr; 2015 Aug; 114(3):398-405. PubMed ID: 26244901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients.
    Hwang YH; Son MJ; Yang J; Kim K; Chung W; Joo KW; Kim Y; Ahn C; Oh KH
    Perit Dial Int; 2009; 29(1):81-8. PubMed ID: 19164257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane.
    Gillerot G; Goffin E; Michel C; Evenepoel P; Biesen WV; Tintillier M; Stenvinkel P; Heimbürger O; Lindholm B; Nordfors L; Robert A; Devuyst O
    Kidney Int; 2005 Jun; 67(6):2477-87. PubMed ID: 15882295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study.
    Szeto CC; Law MC; Wong TY; Leung CB; Li PK
    Am J Kidney Dis; 2001 Feb; 37(2):329-36. PubMed ID: 11157374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 gene polymorphisms and peritoneal equilibration test results in CAPD patients.
    Ebinç FA; Derici U; Gönen S; Reis KA; Erten Y; Bali M; Sindel S; Arinsoy T
    Ren Fail; 2008; 30(1):15-9. PubMed ID: 18197538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
    Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.
    Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV
    Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients.
    Szeto CC; Chow KM; Poon P; Szeto CY; Wong TY; Li PK
    Kidney Int; 2004 May; 65(5):1947-55. PubMed ID: 15086939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal microvascular endothelial function and the microinflammatory state are associated with baseline peritoneal transport characteristics in uremic patients.
    Teng L; Chang M; Liu S; Niu M; Zhang Y; Liu X; Yu X
    Int Urol Nephrol; 2015 Jan; 47(1):191-9. PubMed ID: 25000894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.
    Yang X; Zhang H; Hang Y; Yan H; Lin A; Huang J; Ni Z; Qian J; Fang W
    Am J Nephrol; 2014; 39(6):459-65. PubMed ID: 24854010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between dialysate interleukin-6 and Tie-2 and peritoneal solute transport rate and outcomes for patients undergoing peritoneal dialysis: A prospective cohort study.
    Hang Y; Yan H; Zhang H; Li Z; Fang W
    Pak J Med Sci; 2021; 37(4):1104-1110. PubMed ID: 34290791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.
    Rodrigues AS; Almeida M; Fonseca I; Martins M; Carvalho MJ; Silva F; Correia C; Santos MJ; Cabrita A
    Nephrol Dial Transplant; 2006 Mar; 21(3):763-9. PubMed ID: 16332703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Polymorphisms and Peritoneal Membrane Function.
    Siddique I; Brimble KS; Walkin L; Summers A; Brenchley P; Herrick S; Margetts PJ
    Perit Dial Int; 2015; 35(5):517-29. PubMed ID: 25395500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic.
    Szeto CC; Poon P; Szeto CY; Wong TY; Lai KB; Li PK
    Am J Kidney Dis; 2002 May; 39(5):1061-7. PubMed ID: 11979351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.